Phosgene, an acylating agent, is a very potent inducer of pulmonary edema. Subchronic effects of phosgene in laboratory animals are not well characterized. The purpose of the study was to elucidate potential long-term effects on collagen and elastin metabolism during pulmonary injury/recovery and obtain information about the concentration X time (C X T) behavior of low levels of phosgene. Male Fischer 344 rats (60 days old) were exposed either to clean air or phosgene, 6 hr/day: 0.1 ppm (5 days/week), 0.2 ppm (5 days/week), 0.5 ppm (2 days/week), and 1.0 ppm (1 day/week), for 4 or 12 weeks. A group of rats was allowed clean air recovery for 4 weeks after 12 weeks of phosgene exposure. This exposure scenario was designed to provide equal C x T product for all concentrations at one particular time point except for 0.1 ppm (50% C X T). Phosgene exposure for 4 or 12 weeks increased lung to body weight ratio and lung displacement volume in a concentration-dependent manner. The increase in lung displacement volume was significant even at 0.1 ppm phosgene at 4 weeks. Light microscopic level histopathology examination of lung was conducted at 0.0, 0.1, 0.2, and 1.0 ppm phosgene following 4 and 12 and 16 weeks (recovery). Small but clearly apparent terminal bronchiolar thickening and inflammation were evident with 0.1 ppm phosgene at both 4 and 12 weeks. At 0.2 ppm phosgene, terminal bronchiolar thickening and inflammation appeared to be more prominent when compared to the 0.1 ppm group and changes in alveolar parenchyma were minimal. At 1.0 ppm, extensive inflammation and thickening of terminal bronchioles as well as alveolar walls were evident. Concentration rather than C X T seems to drive pathology response. Trichrome staining for collagen at the terminal bronchiolar sites indicated a slight increase at 4 weeks and marked increase at 12 weeks in both 0.2 and 1.0 ppm groups (0.5 ppm was not examined), 1.0 ppm being more intense. Wholelung prolyl hydroxylase activity and hydroxyproline, taken as an index of collagen synthesis, were increased following 1.0 ppm phosgene exposure at 4 as well as 12 weeks, respectively. Desmosine levels, taken as an index of changes in elastin, were increased in the lung after 4 or 12 weeks in the 1.0 ppm phosgene group. Following 4 weeks of air recovery, lung hydroxyproline was further increased in 0.5 and 1.0 ppm phosgene groups. Lung weight also remained significantly higher than the controls; however, desmosine and lung displacement volume in phosgene-exposed animals were similar to controls. In summary, terminal bronchiolar and lung volume displacement changes occurred at very low phosgene concentrations (0.1 ppm). Phosgene concentration, rather than C X T product appeared to drive toxic responses. The changes induced by phosgene (except of collagen) following 4 weeks were not further amplified at 12 weeks despite continued exposure. Phosgene-induced alterations of matrix were only partially reversible after 4 weeks of clean air exposure, c 1997 sod«y or To
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2 The research described in this article has been reviewed by the National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, and approved for publication. Approval does not signify that the contents necessarily reflect the views and the policies of the Agency nor does mention of trade names or commercial products constitute endorsement or recommendation for use. Phosgene, a widely used intermediate in the synthesis of chemicals and plastics, is a highly reactive acylating agent (chemical formula: COC1 2 ). It is known to induce noncardiogenic pulmonary edema upon acute inhalation exposure Pawlowski and Frosolono, 1977; Diller et al., 1985) . Although environmental levels are relatively low, reaching to about 60 parts per trillion in the urban areas such as Los Angeles, occupational hazards resulting from accidental exposure are well known (Galdston et al., 1947; Gerritsen and Buschmann, 1960; Sjogren et al., 1991) . Likewise, emissions from industrial facilities may pose episodic risks to the public living nearby (Davis et al., 1989) . The acute toxicity of phosgene has been reported to, involve oxidative tissue damage and pulmonary edema due to increased vascular permeability (Franch and Hatch, 1986; Kennedy et al., 1989) , which may involve arachidonic acid metabolites (Guo et al., 1990) . Exposure to phosgene is also known to induce pulmonary inflammation in rats (Currie et al., 1987) . Impaired alveolar macrophage function and clearance of microorganisms from the lung as a result of subchronic phosgene exposure have also been reported (Selgrade et al., 1995) . At lower concentrations, phosgene appears to preferentially deposit in and affect terminal bronchioles, whereas at higher concentrations phosgene damage clearly extends to include alveolar epithelial cells (Gross et al., 1965; Pawlowski and Frosolono, 1977) . It has been suggested that the mechanism of action of phosgene is similar to that of ozone and other oxidants (Kennedy et al., 1989; Ghio et al., 1991) .
Although residual chronic lung injury has been noted in humans accidentally exposed to phosgene (Cucinell and Arsenal, 1974) , long-term, low-level chronic effects are largely unknown. Indeed, systematic chronic toxicity studies in rodents using low levels of this common fugitive emission have not been conducted. Pulmonary emphysema and obliterative bronchitis have been reported in dogs following highlevel phosgene exposure (Clay and Rossing, 1964) . We hypothesized that while high-level phosgene exposures are associated with destructive emphysema in humans and animals, low-level, longer-term phosgene exposures will affect the structural integrity and induce remodeling of the rat lung connective tissues.
Because phosgene is known to be emitted by industrial activities, both protracted low-level and incidental high-level releases into the air are expected; therefore, there is a regulatory need to assess the relative importance of these potential exposure scenarios. It has been proposed that physiological and toxic effects of phosgene exposure are proportional to the concentration X time (C X 7) product (Rinehart and Hatch, 1964) . A primary objective of this study was to investigate the relationship between toxicity and the C X T product in a subchronic format to ascertain the relative importance of peak concentration, frequency of exposure, and total dose to the lesion observed. We report here that pulmonary changes were observed at phosgene concentrations as low as 0.1 ppm, which is the current TLV. Also, it appears that the phosgene-induced changes were primarily determined by concentration rather than C XT product. Moreover, these lesions were only partially reversible, suggesting that phosgene exposures even at low levels may be deleterious to the lung.
METHODS
Animals. Specific pathogen-free male Fischer-344 (F344) rats, CDF*(F344)/CiiBr (260-300 g, 60 days old), were purchased from Charles River Breeding Laboratories (Kingston, NY). The animals were housed in temperature-and humidity-controlled (72 ± 2°F and 50 ± 5% relative humidity), AAALAC-approved animal facilities with a 12-hr light/dark cycle and were fed certified rat chow (Agway Inc. Country Foods Division, Syracuse, New York) ad libitum. A group of rats was tested for presence of specific pathogen at the time of arrival, at the start of exposure, and periodically thereafter until the end of experiment, and they were found to be specific pathogen free.
Phosgene exposure. Rats were housed in large 2.0-m 3 Hazelton 2000 (0.0, 0.1, 0.2, and 0.5 ppm groups) and small 0.3-m 3 Rochester inhalation chambers (0.0 and 1.0 ppm groups) (approved by AAALAC) during phosgene exposure. Animals housed in Hazelton chambers remained in the chamber during nonexposure periods; however, animals housed in Rochester inhalation chambers were relocated to the animal colony. No significant differences in body weight gain (large chambers vs small chambers; 4 weeks, 251.5 ± 17.9 vs 244.7 ± 10.5; 12 weeks, 319.2 ± 11.9 vs 309.7 ± 13.3; 16 weeks, 355.3 ±23.5 vs 347.1 ± 14.5) or in any other parameters occurred between two different control groups housed in two different settings. Following 12 weeks of phosgene exposure all recovery group animals were housed in animal colony for 4 weeks of recovery period. Animals were randomly assigned to different groups using a computerbased weight-matched randomization program. A mass-flow controller (Tylan, Torrance, CA) metered phosgene (300 ppm in nitrogen; Matheson Gas Products, Morrow, GA), with an airflow of 1.0 m 3 /min for Hazelton chambers and 0.32 mVmin for Rochester inhalation chambers. The gas mixture passed downward through the cages holding the test animals and was exhausted at the bottom into a water scrubber. Temperature and humidity in the chambers as well as in the animal colony were (mean ± SD) 23.0 ± 4°C and 50 ± 10%, respectively. Control animals were placed simultaneously in an identical chamber and allowed to breath filtered air.
Phosgene concentrations in the chambers were determined with HewlettPackard 5880 and 5840 gas chromatographs. Methane (5%) in argon (P-5) was used as the carrier phase. For Model 5880, a fused silica capillary column, SPB-1, was used (Supelco Inc., Bellefonte, PA) with a flow rate of 30.0 ml/min. The column temperature was maintained at 35°C. For Model 5840, a 10% SP-2100, 80/100 Supelcoport SS 1/8" column (Supelco, Bellefonte, PA) was used with a flow rate of 30 ml/min. Column temperature was maintained at 40°C during operation. Prior to the start of phosgene exposure, an appropriate representative sampling port was determined by analyzing samples collected at various locations within the chamber. During exposure, phosgene concentrations were monitored once every 20 min from a representative sampling port. The 12-week average chamber phosgene concentrations were (mean ± SD ( Rats were exposed to either air or phosgene, 6 hr/day at 0.1 (5 days/ week), 0.2 (5 days/week), 0.5 (2 days/week), or 1.0 ppm (I day/week) in order to derive equal C X T product for one particular time point except in the 0.1 ppm group (50% C X T). The experimental protocol and number of animals used in each group are depicted in Table 1 . At the end of 4 or 12 weeks of phosgene exposure, or 4 weeks of clean air recovery after 12 weeks of phosgene exposure, rats were killed and the lungs analyzed.
Lung fixation and displacement volume measurements.
Rats were anesthetized with urediane (1.0 g/ml/kg body wt), the abdomen was opened, blood was removed by exsanguination of the dorsal aorta, and the trachea was cannulated. The left lung was used for histopathology and the right lung was used for biochemical analysis. The right lung was tied, and then the lung lobes were clipped off and weighed. Following lung weight measurements, the lobes were quickly frozen in liquid nitrogen and stored at -80°C until analyzed. The trachea with the left lung attached was suspended in a petri dish containing distilled water and inflated to 25 cm water transpulmonary pressure with 2.5% glutaraldehyde/0.16 M cacodylate buffer. Thirty min postinflation, the lung was removed and the displacement volume was obtained. The fixed tissues were then stored in 10% buffered formalin until further processing.
Histopathology.
Midsagittal sections (4 fim) of the lung tissue were prepared from paraffin blocks and mounted on glass microscope slides. Slides were stained with Masson's Trichrome stain for identification of collagen fibers and counter stained with hematoxylin and eosin. Lung sections were examined under a light microscope. Histopathological evaluation of these lung tissues was done in a blinded manner for exposure group designation (Experimental Pathology Laboratory, Research Triangle Park, NQ. " Since large and small chambers were used for exposure to phosgene, two separate air control groups were run simultaneously. 6 Number of animals used per group.
Biochemical assays. The right caudal lobe was used for hydroxyproline and desmosine analysis and the rest of the lobes were used for prolyl hydroxylase assay. The right lung lobes (except a caudal lobe) were thawed and homogenized in cold 20 mAf Tris-HC1 buffer, pH 7.6. Prolyl hydroxylase activity was measured as the enzyme-catalyzed release of tritiated water from L- [3,4- 3 H]proline-labeled procollagen (Gin el ah, 1983) . For hydroxyproline and desmosine analysis the caudal lobes were lyophilized and then hydrolyzed in 6 M hydrochloric acid at 110°C for 16 hr. The hydrolyzate was filtered through 0.45-^m Teflon filters. A portion of the filtrate was then neutralized using 6 M sodium hydroxide to a pH of 7-7.5 and the samples were diluted for calorimetric detection of hydroxyproline as described (Bergman and Loxley, 1961 ). An aliquot of filtrate was dried under nitrogen. The residue was resuspended in water and dried in order to completely eliminate hydrochloric acid from the sample. The dried samples were then suspended in water and analyzed for desmosine by radioimmunoassay (Starcher, 1982) .
Statistics.
A multivariate analysis of variance (MANOVA) (SAS 516; SAS Institute, Cary, NC) was used. According to the study protocol, if significant (p as 0.1) multivanate time, exposure, or exposure by time interaction effects were found, further univariate analysis using the same analysis model as that used in the MANOVA were performed. Corrected pairwise comparisons were used as subtests to evaluate differences between exposure groups. The Type I error rate was set at p = 0 05 for significance. Control values (air chambers) for large and small chambers were pooled because no statistical differences were noted between the animals exposed in two chambers in any of the parameters measured at any time. Data represents the mean ± SE of 10-12 controls or 8 exposed rats.
RESULTS

Lung Weight and Displacement Volume Changes
There was a small but significant decrease in weight gain in rats exposed to 0.5 and 1.0 ppm phosgene at 4 and 12 weeks ( Fig. 1 A) ; therefore, lung to body weight ratios were taken into account in determining the effect on the lung weight. Lung to body weight ratios were increased in a concentration-dependent manner at 4 and 12 weeks of phosgene exposure (Fig. IB) . The phosgene concentration at either time point seemed to drive this response rather than the C X T product. The effect appeared to be more severe at the end of 4 weeks than after 12 weeks of exposure. After 4 weeks of clean air recovery following 12 weeks of phosgene exposure, the lung to body weight ratio remained slightly, but significantly, higher in the 1.0 ppm phosgene-exposed animals. Phosgene also increased the lung displacement volume (measured for the left lung and normalized to body weight) in a concentration-dependent manner (Fig. 1C) . Measurement of displacement volume is taken as an index of change in the total lung volume (Scherle, 1970) . The effect was significant even at 0.1 ppm at 4 weeks. The increase in displacement volume at 4 weeks was not further amplified following 12 weeks despite continued exposure. Following 4 weeks of clean air recovery, the displacement volumes returned to control levels regardless of phosgene concentration.
Histopathology and Collagen Changes
Light microscopic examination was done only at 0.0, 0.1, 0.2, and 1.0 ppm phosgene following 4 and 12 weeks of exposure and recovery (the 0.5 ppm samples were inadvertently lost). It was possible to compare pathology of two groups with equal C X T (0.2 and 1.0 ppm) instead of three. Pulmonary histopathological changes were associated with phosgene exposure and were concentration dependent (Tables 2 and 3). Phosgene appeared to affect all animals in a consistent manner within a group. The changes occurred primarily at the terminal bronchiolar regions at low phosgene concentrations (0.1 and 0.2 ppm). The more peripheral areas were affected at 1.0 ppm. The severity of the pathological changes in the lung seemed to depend upon phosgene concentrations rather than the C X T product based on subjective screening of the degree of injury (Tables 2 and 3) .
Four-week phosgene exposure. Controls for both chambers as well as phosgene-exposed animals were scored for severity of lesions such as epithelial alterations including Values are means ± SE of 12 air controls or 8 phosgene exposed rats. Asterisks (•) indicate p < 0.05 compared to matching air-exposed group. The time point at 12 + 4 weeks indicate 12 weeks of exposure followed by 4 weeks of air recovery. inflammation in major airways, alveolus/interstitial thickening, terminal bronchiole/alveolus inflammatory cell influx as well as epithelial alterations and increased terminal bronchiole/peribronchiolar collagen staining (Tables 2 and 3 ). All air-exposed animals had normal terminal bronchiolar regions, airways, and alveoli with none to minimal inflammation or any other changes occurring at any time points examined (Tables 2 and 3 ; Fig. 2A) . Following phosgene exposure, the changes at the terminal bronchiolar and surrounding areas were characterized by thickening of the bron- chioles as well as alveolar walls with infiltration of inflammatory cells (Figs. 2B-2D ). At 0.1 ppm phosgene, a small but readily apparent terminal bronchiolar thickening was noticed at the light microscopic level with an increased number of inflammatory cells (Fig. 2B ). Pathology severity scoring and incidence data indicated that changes seen at 0.1 ppm could be distinguished from control groups (Tables 2 and  3 ). These changes were much more apparent at 0.2 ppm, and seemed to be uniformly distributed in all terminal bronchioles within the section. At 1.0 ppm phosgene, more severe inflammation and thickening were noticeable at the terminal bronchiolar regions and alveolar walls (Fig. 2D ). There was an increase in collagen stain within thickened terminal bronchioles at 0.2 and 1.0 ppm (0.5 ppm animals were not examined) following 4 weeks of exposure (Figs. 2C and 2D ). The staining was much more intense at 1.0 ppm phosgene. Although there was an increase in collagen staining at terminal bronchiolar regions and surrounding alveolar sites, especially at 1.0 ppm, fibrotic patches were less apparent within the alveolar parenchyma.
Twelve-week phosgene exposure. Despite continual exposure, the inflammatory cell influx at the terminal bronchiolar area and surrounding pleura was not further increased following 12 weeks of exposure when compared to 4 weeks for any phosgene concentrations examined (Tables 2 and 3; Figs. 2E and 2F). Slight terminal bronchiolar thickening was noted at 0.1 ppm with very few inflammatory cells (not shown). The intensity of collagen stain increased following exposure for 12 weeks at both 0.2 and 1.0 ppm in the terminal bronchiolar region; Figs. 2E and 2F). At 1.0 ppm phosgene, in addition to the terminal bronchiolar changes, there was marked alveolar wall thickening and inflammation, giving an appearance of rounded alveolar spaces (Fig. 2G) . Fibrotic lesions involving multialveolar units were minimal in rats exposed to 0.1 or 0.2 ppm and only slightly apparent at 1.0 ppm phosgene (not shown).
Twelve-week phosgene exposure plus 4-week air recovery.
Histopathology following 4 weeks of clean air recovery (12 + 4 weeks groups) indicate almost complete resolution of inflammation with residual inflammatory cells and epithelial cell alterations (Tables 2 and 3 ). The 0.1 ppm phosgene group appeared to be similar to air-exposed controls (not shown). Terminal bronchiolar thickening and inflammation in the 0.2 ppm phosgene-exposed animals appeared to have resolved considerably (Fig. 2H) . Collagen staining remained at the same level of intensity as seen in 12-week groups of 0.2 and 1.0 ppm (Tables 2 and 3) .
Prolyl hydroxyla.se, hydroxyproline, and desmosine following phosgene exposure. Hydroxyproline and prolyl hydroxylase activity were measured in a lung lobe as a measure of increased collagen synthesis following phosgene exposure. Prolyl hydroxylase activity was significantly increased over air controls at 1.0 ppm phosgene following either 4 or 12 weeks of exposure. The increase was of similar magnitude at either time point (Fig. 3A) . Prolyl hydroxylase activity returned to control levels by the end of the recovery period. Total hydroxyproline, measured as an index of collagen deposition, was significantly elevated at the 1.0 ppm phosgene concentration following 12 weeks of exposure (Fig. 3B) . At 4 weeks (1.0 ppm phosgene), the hydroxyproline level appeared to be higher than that in the air-exposed controls; however, the difference was Jiot statistically significant. Right lung hydroxyproline levels appeared to have further increased following 4 weeks of air recovery (Fig. 3B) . The increase at this time was significant at 0.5 and 1.0 ppm phosgene. Analysis of variance also indicated a significant time related increases in hydroxyproline in the air exposed "Severity score given to individual animal from a complete pathological examination are 0, not remarkable; 1, minimal; 2, slight/mild; 3, moderate; 4, moderately severe; and 5, severe, based upon relative evaluation of lesions. Based on severity scoring, a maximum of score 3 was assigned for some of the lesion types at highest phosgene concentrations. Severity scores for each animal within a group were added and an average score per animal was calculated which is shown in the table.
animals during the 16 weeks of the experiment as would be expected based on the lung growth with age.
Lung desmosine concentrations were measured as an index of elastin content of the lung tissue. Desmosine was significantly increased at the 1.0 ppm phosgene concentration following 4 and 12 weeks of exposure. After 4 weeks of recovery, although the desmosine level appeared to be higher than that in the air-exposed controls, the difference was not statistically significant (Fig. 3C ). There was a significant time-dependent increase in lung desmosine levels in air-exposed controls. This effect appeared to be similar to that of hydroxyproline and reflects age-related lung growth.
DISCUSSION
Acute pulmonary effects of phosgene exposures at high concentrations are associated with edema and bronchiolitis in animals Pawlowski and Frosolono, 1977; Guo et al., 1990 ). Here we report that verylow-level subchronic phosgene exposures (0.1 ppm, 6 hr/ day, 5 days/week) for a period of 4 weeks in rats are associated with pathological abnormalities in the lung. Small microscopical changes at the terminal bronchiolar regions and also small but significant increases in the lung volume displacement occurred at phosgene concentrations as low as 0.1 ppm. This suggests that changes in the displacement volume can be detected at the level at which very subtle histopathological abnormalities occur and may represent a very sensitive indicator of lung structural changes following phosgene exposure. This concentration of phosgene (0.1 ppm) is the current TLV for 8 hr/day, 5 days per week exposure over a life time and thus is regarded as safe for humans.
Our results indicate that in subchronic phosgene exposure scenarios at low concentrations, the effects (i.e., thickening and inflammation) are primarily associated with the terminal bronchiolar areas and are not as pronounced in the alveolar regions. It was also apparent that at the highest phosgene concentration (1.0 ppm) alveolar parenchyma, in addition to the terminal bronchioles, was thickened and inflamed despite a C X T product that was identical to that of the 0.2 ppm exposure group, suggesting that phosgene concentration is the primary determinant of the injury and the degree of pathological damage within the lung. This dominant effect of concentration (over time of exposure) has been demonstrated with other endpoints, including pulmonary function tests, lavage fluid protein (unpublished observations), and host resistance to bacterial infections (Selgrade et al., 1995) . Acute exposure studies using high phosgene concentrations, which demonstrate development of emphysema and damage to the alveolar walls (Clay and Rossing, 1964; Pawlowski and Frosolono, 1977) , support the present findings of peripheral alveolar damage at higher phosgene concentrations. Changes in the alveolar parenchyma at higher phosgene concentrations would be consistent with a proportionately greater dose reaching the alveolar units, resulting in a more severe alveolar injury. A similar pattern of dose and injury has been previously noted after ozone exposure in animals (Pinkerton et al., 1995) . Also, the pathological changes that we observed at the terminal bronchiolar sites following phosgene exposure were similar to those reported following ozone and nitrogen dioxide exposures in animals (Freeman et al., 1974) , suggesting that perhaps the mechanism of lung injury following phosgene exposure may be similar to that of other oxidant air pollutants (Kennedy et al., 1989; Ghio et al., 1991) .
Evidence of increased hydroxyproline concentrations following a subchronic phosgene exposure of 0.25 ppm has been reported previously (Franch and Hatch, 1986) . Our studies also indicate that subchronic phosgene exposure is associated with an increase in whole-lung hydroxyproline, but only at 1.0 ppm. Although quantitative analysis of whole lung hydroxyproline revealed an increase only after 1.0 ppm phosgene exposure, trichrome staining of lung sections indicated that collagen deposition occurred in terminal bronchioles even at 0.2 ppm phosgene. Thus, as we have previously reported with ozone in guinea pigs, whole-tissue analysis of hydroxyproline may have diluted the more localized effects seen on collagen deposition (Kodavanti et al., 1995) . Analysis of lung tissue hydroxyproline has been used as an index of fibrosis. However, the pattern of collagen deposition in the tissue and its relation with the pathological appearance of fibrotic foci should be carefully evaluated since considerable collagen deposition at the thickened terminal bronchiolar regions can occur without evidence of multialveolar fibrotic lesions. At 1.0 ppm, the increases in lung hydroxyproline in rats probably reflects collagen accumulation at both thickened terminal bronchioles and alveolar walls which appear to show remodeling of the parenchyma.
Increased collagen deposition may be attributable to stimulated collagen synthesis since prolyl hydroxylase activity was also increased following phosgene exposure. The increase in prolyl hydroxylase activity in the whole lung tissue homogenate coincided with an increase in hydroxyproline at 4 and 12 weeks of 1.0 ppm phosgene exposure. Although prolyl hydroxylase activity returned to control levels during recovery, lung hydroxyproline continued to accumulate, perhaps as a result of slower collagen degradation in addition to continued synthesis. Induction of prolyl hydroxylase activity in the lung has been reported following extended ozone exposures in animals (Hussain et al., 1976; Hesterberg and Last, 1981; Bhatnagar et al., 1982; Kodavanti et al., 1995) . Since we observed an increase in collagen at the terminal bronchiolar regions with concentrations as low as 0.2 ppm phosgene, it is likely that prolyl hydroxylase was also induced in a site specific manner in those terminal bronchiolar regions.
The development of lung emphysema can be correlated with a loss of elastin in the alveolar walls. Since emphysema has been previously reported in animals following phosgene exposure (Clay and Rossing, 1964) , we hypothesized that emphysema might result from our phosgene exposure scenarios, with or without a concurrent increase in collagen. However, analysis of lung desmosine following phosgene exposure indicated an increase in elastin rather than a decrease. One possible explanation is that the rounding of alveolar spaces, such as that seen at 1.0 ppm phosgene, is likely associated with an increase in tissue matrix production in the alveolar walls. The increase in lung desmosine may be indicative of tissue remodeling and perhaps is a reflection of the terminal bronchiolar and alveolar wall thickening that was observed histologically. Concurrent increases in collagen and elastin have been reported for animal models of fibrotic lung diseases (Costa et al., 1983) .
In the past, C X T products have been used in calculating cumulative dose/effects of a toxic substances (Rinehart and Hatch, 1964; Cucinell and Arsenal, 1974) and are currently used in computing reference concentrations (Jarabek, 1994) . However, in most of the acute experimental scenarios, concentration alone appears to drive toxic response rather than cumulative dose. In the exposure scenarios examined in the present study, concentration also appeared to drive all indicators of the toxicity. For example, pathology, changes in lung weight and volumes, and changes in hydroxyproline and desmosine that occurred at 0.2 ppm (6 hr/day, 5 days/week for 4 or 12 weeks) were much less evident than those observed at 1.0 ppm (6 hr/day, 1 day/week for 4 or 12 weeks), despite the fact that the C X T products were similar at these phosgene concentrations at one given time. In addition, changes observed after 12 weeks were not three times greater than those of 4 weeks, despite the C X T product being three times higher at 12 weeks. In summary, low-level subchronic phosgene exposure (0.1 ppm, current TLV) resulted in histological changes at the terminal bronchioles and changes in lung displacement volumes. Hydroxyproline increases in the lung following phos- , and desmosine (C) following subchronic phosgene exposure in rats. Values are means ± SE of 12 air controls or 8 phosgene exposed rats. Asterisks (•) indicate P < 0.05 compared to matching air exposed group. gene exposure were reflective of increased collagen primarily at terminal bronchiolar regions. Enlargement of alveolar the C X T product, spaces may occur at high phosgene concentrations. However, this may not be consistent with frank emphysema, since significant alveolar wall and terminal bronchiolar remodeling may reflect paracintrial disease and not overt interstitial degeneration. Phosgene-induced changes in collagen were not reversible within 4 weeks of recovery period. Finally, the severity of lesions was dependent on concentration, not
